Centice and Medi-Span® to present new interface for PASS Rx® at APhA

Morrisville, NC (April 2, 2009) – Centice Corporation, the pioneer in drug verification and safety, announced today a partnership with Medi-Span, the most trusted name inside drug applications.

Increased script volume, fewer resources and manual subjective verification methodologies can unfortunately result in greater risk of medication errors in the pharmacy. PASS Rx is the first and only product that utilizes patented spectroscopy and machine vision sensor technologies to confirm the accuracy of a retail pharmacy’s dispensed solid dose medications in a matter of seconds. Centice technologies have additional applicability beyond the verification of solid medications in the pharmacy, and the company has plans to develop future products for liquid medication verification and counterfeit drug detection.

In addition to sensor verification of the drug type and strength of oral solid medications, PASS Rx will now also incorporate Wolters Kluwer Health’s Medi-Span Drug Image Database™ v2.0 and Drug Imprint Database™ v2.0 to provide additional valuable content on thousands of prescription and OTC medications, regardless of form and packaging. This allows pharmacy professionals to also visually verify a drug being dispensed against high-resolution images and descriptions of the prescribed medication.

The Medi-Span product line is comprised of drug and clinical information databases that can be embedded in a wide range of healthcare applications, including retail pharmacy, pharmacy benefit management, claims processing and electronic medical records.

Together with Medi-Span’s data, PASS Rx provides a unique comprehensive system for enhanced verification of the medication before it is given to the patient, scientifically and visually.

“Centice is dedicated to offering solutions for improving patient safety as well as pharmacy quality,” said Ray W. Swanson, President and CEO of Centice. “We are pleased that PASS Rx now offers our customers even more value for every prescription being verified in the pharmacy,” he added.

“Wolters Kluwer Health has led the market on a number of drug information-related patient safety measures, including the use of Tall Man lettering, patient-specific dosing modules and actionable drug interaction information,” said Arvind Subramanian, CEO, Wolters Kluwer Health Clinical Solutions. “Our partnership with Centice Corporation means that our joint customers now have access to the most powerful drug verification solutions on the market,” he added.

Visit booth #1821 for a demonstration of PASS Rx at the 2009 American Pharmacists Association (APhA) Annual Meeting and Exposition in San Antonio, TX from April 4-6.

About Medi-Span

Medi-Span® is the leading provider of drug information for thousands of health care professionals worldwide. With more than 30 years experience, Medi-Span continues to offer authoritative drug databases in a variety of formats, including clinical decision support and disease suite modules, application programming interfaces and stand-alone software applications. In conjunction with superior implementation and experienced customer support, the Medi-Span product line is the perfect choice for those needing accurate, trusted, drug data that easily integrates into existing software applications. Medi-Span is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry.

Wolters Kluwer Health is a division of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of €3.4 billion ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit wwww.wolterskluwer.com for information about our market positions, customers, brands, and organization.

About Centice Corporation

Centice, founded in 2004 and headquartered in RTP, NC, is commercializing patented and patent-pending computational sensor and machine vision technology. The PASS Rx® pharmaceutical authentication sensor system improves the verification process for dispensed medications, thereby increasing efficiency and optimizing workflow in the pharmacy. The company has received venture capital investments from The Aurora Funds, Inc., Novak Biddle Venture Partners, S-Group Direct Investments Ltd, Innovation Ventures LP, and other private investors. More information on Centice can be found at www.centice.com.